000			02059 a2200577 4500
005			20250515230852.0
264		0	_c20101015
008			201010s 0 0 eng d
022			_a1873-3476
024	7		_a10.1016/j.ijpharm.2010.05.028 _2doi
040			_aNLM _beng _cNLM
100	1		_aGalmarini, Carlos M
245	0	0	_aEfficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs. _h[electronic resource]
260			_bInternational journal of pharmaceutics _cAug 2010
300			_a281-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650	0	4	_aAnimals
650	0	4	_aAntimetabolites, Antineoplastic _xchemistry
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aBiological Transport
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aChemistry, Pharmaceutical
650	0	4	_aCytarabine _xchemistry
650	0	4	_aDeoxycytidine _xanalogs & derivatives
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Carriers
650	0	4	_aDrug Resistance
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aGels
650	0	4	_aHumans
650	0	4	_aInhibitory Concentration 50
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Nude
650	0	4	_aNanoparticles
650	0	4	_aNanotechnology
650	0	4	_aPhosphorylation
650	0	4	_aProtein Tyrosine Phosphatase, Non-Receptor Type 22 _xmetabolism
650	0	4	_aTechnology, Pharmaceutical _xmethods
650	0	4	_aTime Factors
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_aGemcitabine
700	1		_aWarren, Galya
700	1		_aSenanayake, Madapathage T
700	1		_aVinogradov, Serguei V
773	0		_tInternational journal of pharmaceutics _gvol. 395 _gno. 1-2 _gp. 281-9
856	4	0	_uhttps://doi.org/10.1016/j.ijpharm.2010.05.028 _zAvailable from publisher's website
999			_c19928646 _d19928646